Lawrence Montalto, DO
Pain Medicine · Shallotte, NCNPI 1669891206
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 63.7% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $8,976, 4.9 times the $1,833 reported in 2019.
Across 317 payments — averaging $50.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$10K
- Boston Scientific$2K
- Medtronic$1K
- Relievant Medsystems, Inc.$794
- Nevro Corp.$731
- Saluda Medical Americas, Inc.$601
- plus $848 from 16 others
What the payments were for
- Speaking & faculty fees$5,22533%
- Travel & lodging$4,09726%
- Food & beverage$6,64942%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 111 | $10,170 |
| Boston Scientific | 43 | $1,677 |
| Medtronic(2 entities) | 49 | $1,150 |
| Relievant Medsystems, Inc. | 8 | $794 |
| Nevro Corp. | 28 | $731 |
| Saluda Medical Americas, Inc. | 35 | $601 |
| Si-bone, Inc. | 9 | $165 |
| Amgen | 1 | $122 |
| AbbVie(2 entities) | 7 | $102 |
| Biotronik NRO, Inc. | 4 | $100 |
| Collegium Pharmaceutical, Inc. | 6 | $90 |
| SPR Therapeutics, Inc | 2 | $42 |
| Globus Medical | 2 | $36 |
| Merz Pharmaceuticals, LLC | 1 | $26 |
| BD | 1 | $25 |
| Pacira Therapeutics, Inc. | 1 | $25 |
| Forte Bio-pharma LLC | 3 | $25 |
| Nalu Medical, Inc. | 1 | $24 |
| Biodelivery Sciences International, Inc. | 2 | $24 |
| Painteq LLC | 1 | $21 |
| Pfizer | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$7,120
- Intracept$1,500
- Proclaim Family of SCS IPGs$1,135
- SUPERION$607
- INTELLIS ADAPTIVESTIM$307
- AIMOVIG$122
- Senza$117
How this compares
$15,970 in reported general payments places this provider in the 85th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 249 | $3,116 |
| Pregabalin | 95 | $1,762 |
| Diclofenac Sodium | 30 | $1,157 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $814 |
| Meloxicam | 142 | $742 |
| Celecoxib | 12 | $288 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $244 |
| Tizanidine Hcl | 20 | $191 |
| Tramadol Hcl | 36 | $161 |
| Methylprednisolone | 15 | $90 |
| Alprazolam | 20 | $14 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Shallotte
- James NorthWinston Salem$721K
- Leonardo KapuralWinston Salem$523K
- Christopher GilmoreWinston Salem$457K
- Richard RauckWinston Salem$431K
- Courtney AumanJacksonville$186K
- Jacob WangCharlotte$162K
- Aashish KumarCharlotte$160K
- Javid BakshAsheville$116K
- David ZubLeland$97K
- James DeeringCharlotte$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.